Propranolol-exacerbated mesenteric ischemia in a patient with hyperthyroidism

Annals of Pharmacotherapy

Volumn 39, Issue 3, 2005, Pages 559-562

  Şeref Köksal, Aydin ^a   Üsküdar, Oǧuz ^a   Köklü, Seyfettin ^a   Yüksel, Osman ^b   Beyazit, Yavuz ^c   Şahin, Burhan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Hyperthyroidism; Ischemic colitis; Mesenteric ischemia; Propranolol

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CIPROFLOXACIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METRONIDAZOLE; PROPRANOLOL; PROPYLTHIOURACIL;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DIARRHEA; DISEASE EXACERBATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; INTESTINE ISCHEMIA; ISCHEMIC COLITIS; MALE; PRIORITY JOURNAL; SUPERIOR MESENTERIC ARTERY OBSTRUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANTITHYROID AGENTS; HUMANS; HYPERTHYROIDISM; MALE; MESENTERIC VASCULAR OCCLUSION; MIDDLE AGED; PROPRANOLOL; PROPYLTHIOURACIL;

EID: 13944281279     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E534     Document Type: Article

References (16)

1. Reilley PM, Jones B, Bulkley GB. Noninvasive assessment of ischemic bowel syndromes. In: Ernst CB, Stanley JB, eds. Current therapy in vascular surgery. 2nd ed. Philadelphia: BC Decker, 1991:719.
2. Jacob H, Brandt LJ, Farkas P, Frishman W. Beta-adrenergic blockade and the gastrointestinal system. Am J Med 1983;73:1042-51.
3. Price HL, Cooperman HL, Warden JC. Control of the splanchnic circulation in man. Role of beta-adrenergic receptors. Circ Res 1967;21:333-40.
4. Wilson SE, Bennett G, Winston MA, Jabour A. Potentiation of epinephrine-induced mesenteric vasoconstriction with β-blockade. J Surg Res 1977;23:274-8.
5. Rosch J, Dotter CT, Rose RW. Selective arterial infusion of vasoconstrictors in acute gastrointestinal bleeding. Radiology 1971;99:27-36.
6. Shanks RG. Clinical pharmacology of vasodilatory beta-blocking drugs. Am Heart J 1991;121:1006-11.
7. Dabisch PA, Liles JT, Kadowitz PJ. Effect of inhibition of nitric oxide synthase on the vasopressor response to ephedrine. Can J Physiol Pharmacol 2003;81:966-71.
8. Okajima M, Takamura M, Vequaud P, Parent R, Lavallee M. Beta-adrenergic receptor blockade impairs NO-dependent dilation of large coronary arteries during exercise. Am J Physiol Heart Circ Physiol 2003;284: H501-10.
9. Zwaveling J, Pfaffendorf M, van Zwieten PA. The direct effects of thyroid hormones on rat mesenteric resistance arteries. Fundam Clin Pharmacol 1997;11:41-6.
10. Nilsson H, Goldstein M, Nilsson O. Adrenergic innervation and neurogenic response in large and small arteries and veins from the rat. Acta Physiol Scand 1986;126:121-33.
11. Schneider R. Do beta-blockers cause mesenteric ischemia? J Clin Gastroenterol 1986;8:109-10.
12. Pettei MJ, Levy J, Abramson S. Nonocclusive mesenteric ischemia associated with propranolol overdose: implications regarding splanchnic circulation. J Pediatr Gastroenterol Nutr 1990;10:544-7.
13. Bryant J. Unexpected sudden death during propranolol therapy in a patient with mild mesenteric venous myointimal hyperplasia. J Forensic Sci 1998;43:905-7.
14. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
15. Ottinger LW. The surgical management of acute occlusion of the superior mesenteric artery. Ann Surg 1978;188:721-31.
16. Hildebrand HD, Zierler RE. Mesenteric vascular disease. Am J Surg 1980;139:188-92.